Vertex Stock Market Value

VRTX
 Stock
  

USD 291.16  2.18  0.75%   

Vertex Pharmaceutic's market value is the price at which a share of Vertex Pharmaceutic stock trades on a public exchange. It measures the collective expectations of Vertex Pharmaceutic investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Vertex Pharmaceutic and determine expected loss or profit from investing in Vertex Pharmaceutic over a given investment horizon. Also, please take a look at Vertex Pharmaceutic Hype Analysis, Vertex Pharmaceutic Correlation, Vertex Pharmaceutic Valuation, Vertex Pharmaceutic Volatility, as well as analyze Vertex Pharmaceutic Alpha and Beta and Vertex Pharmaceutic Performance.
Symbol
Backtest


Is Vertex Pharmaceutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceutic. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.19
Market Capitalization
73.9 B
Quarterly Revenue Growth YOY
0.22
Return On Assets
0.14
Return On Equity
0.25
The market value of Vertex Pharmaceutic is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceutic's value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceutic's market value can be influenced by many factors that don't directly affect Vertex Pharmaceutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceutic's value and its price as these two are different measures arrived at by different means. Investors typically determine Vertex Pharmaceutic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vertex Pharmaceutic 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vertex Pharmaceutic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vertex Pharmaceutic.
0.00
06/07/2022
No Change 0.00  0.0 
In 30 days
07/07/2022
0.00
If you would invest  0.00  in Vertex Pharmaceutic on June 7, 2022 and sell it all today you would earn a total of 0.00 from holding Vertex Pharmaceutic or generate 0.0% return on investment in Vertex Pharmaceutic over 30 days. Vertex Pharmaceutic is related to or competes with Pfizer, Zoetis Inc, Boeing, Chevron Corp, Walmart, Alcoa Corp, and Cisco Systems. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for tr...More

Vertex Pharmaceutic Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vertex Pharmaceutic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vertex Pharmaceutic upside and downside potential and time the market with a certain degree of confidence.

Vertex Pharmaceutic Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Vertex Pharmaceutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vertex Pharmaceutic's standard deviation. In reality, there are many statistical measures that can use Vertex Pharmaceutic historical prices to predict the future Vertex Pharmaceutic's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Vertex Pharmaceutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Vertex Pharmaceutic in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
288.37290.85293.33
Details
Intrinsic
Valuation
LowReal ValueHigh
241.02243.50320.28
Details
Naive
Forecast
LowNext ValueHigh
307.55310.03312.51
Details
19 Analysts
Consensus
LowTarget PriceHigh
201.00259.89341.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vertex Pharmaceutic. Your research has to be compared to or analyzed against Vertex Pharmaceutic's peers to derive any actionable benefits. When done correctly, Vertex Pharmaceutic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Vertex Pharmaceutic.

Vertex Pharmaceutic Backtested Returns

We consider Vertex Pharmaceutic very steady. Vertex Pharmaceutic owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0375, which indicates the firm had 0.0375% of return per unit of risk over the last 3 months. Our standpoint towards measuring the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Vertex Pharmaceutic, which you can use to evaluate the future volatility of the company. Please validate Vertex Pharmaceutic Risk Adjusted Performance of 0.1182, coefficient of variation of 1235.83, and Semi Deviation of 2.88 to confirm if the risk estimate we provide is consistent with the expected return of 0.0931%.
Vertex Pharmaceutic has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 1.0495, which indicates a somewhat significant risk relative to the market. Let's try to break down what Vertex's beta means in this case. Vertex Pharmaceutic returns are very sensitive to returns on the market. As the market goes up or down, Vertex Pharmaceutic is expected to follow. Although it is important to respect Vertex Pharmaceutic current price movements, it is better to be realistic regarding the information on the equity's historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting Vertex Pharmaceutic technical indicators, you can presently evaluate if the expected return of 0.0931% will be sustainable into the future. Vertex Pharmaceutic right now has a risk of 2.48%. Please validate Vertex Pharmaceutic value at risk, as well as the relationship between the semi variance and kurtosis to decide if Vertex Pharmaceutic will be following its existing price patterns.

Auto-correlation

    
  0.21  

Weak predictability

Vertex Pharmaceutic has weak predictability. Overlapping area represents the amount of predictability between Vertex Pharmaceutic time series from 7th of June 2022 to 22nd of June 2022 and 22nd of June 2022 to 7th of July 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vertex Pharmaceutic price movement. The serial correlation of 0.21 indicates that over 21.0% of current Vertex Pharmaceutic price fluctuation can be explain by its past prices.
Correlation Coefficient0.21
Spearman Rank Test0.5
Residual Average0.0
Price Variance39.29

Vertex Pharmaceutic lagged returns against current returns

Autocorrelation, which is Vertex Pharmaceutic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vertex Pharmaceutic's stock expected returns. We can calculate the autocorrelation of Vertex Pharmaceutic returns to help us make a trade decision. For example, suppose you find that Vertex Pharmaceutic stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

Vertex Pharmaceutic regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vertex Pharmaceutic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vertex Pharmaceutic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vertex Pharmaceutic stock over time.
 Current vs Lagged Prices 
Share
      Timeline 

Vertex Pharmaceutic Lagged Returns

When evaluating Vertex Pharmaceutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vertex Pharmaceutic stock have on its future price. Vertex Pharmaceutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vertex Pharmaceutic autocorrelation shows the relationship between Vertex Pharmaceutic stock current value and its past values and can show if there is a momentum factor associated with investing in Vertex Pharmaceutic.
 Regressed Prices 
Share
      Timeline 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Vertex Pharmaceutic without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Also, please take a look at Vertex Pharmaceutic Hype Analysis, Vertex Pharmaceutic Correlation, Vertex Pharmaceutic Valuation, Vertex Pharmaceutic Volatility, as well as analyze Vertex Pharmaceutic Alpha and Beta and Vertex Pharmaceutic Performance. Note that the Vertex Pharmaceutic information on this page should be used as a complementary analysis to other Vertex Pharmaceutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceutic price analysis, check to measure Vertex Pharmaceutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceutic is operating at the current time. Most of Vertex Pharmaceutic's value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceutic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vertex Pharmaceutic's price. Additionally, you may evaluate how the addition of Vertex Pharmaceutic to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Vertex Pharmaceutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceutic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceutic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...